Clinical Trials on Health Volunteer in United Kingdom

Total 32192 results

Reata, a wholly owned subsidiary of Biogen

Completed

A Single-Dose, Open-Label, Randomized, Food Effect and Blinded, Randomized, Dose Proportionality Study in Healthy Volunteers With Bardoxolone Methyl

Healthy Volunteers

United States
Laboratoires Thea

Completed

Systemic Pharmacokinetic Study of T4032 (Unpreserved Bimatoprost 0.01%) Eye Gel Versus Lumigan® 0.01% Eye Drops in 40 Healthy Volunteers

Healthy Volunteers

United States
Pfizer

Completed

Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide

Healthy Volunteers

United States
Cassava Sciences, Inc.
Worldwide Clinical Trials

Completed

Food Effect and Bioequivalence Study of Simufilam Tablets in Healthy Volunteers

Healthy Volunteers

United States
Bristol-Myers Squibb
Celgene

Completed

A Study to Compare the Relative Bioavailability of Two Iberdomide (CC-220) Formulations and to Assess The Effect Of Food on the Drug Levels of Iberdomide in Healthy Adult Participants

Healthy Volunteers

United States
Sanofi
Regeneron Pharmaceuticals

Completed

A Study to Investigate the Pharmacokinetics (PK), Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants.

Healthy Volunteers

United States
Venatorx Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

VNRX-7145 SAD/MAD Safety and PK in Healthy Adult Volunteers

Healthy Volunteers

United States
Takeda

Completed

A Study of Danavorexton in Anesthetized Adults

Healthy Volunteers

United States
Bacainn Therapeutics, Inc.

Completed

A Phase 1, Single-Ascending-Dose Study of BT051 in Healthy Subjects

Healthy Volunteers

United States
Pyramid Biosciences

Completed

A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants

Healthy Volunteers

United States
Loxo Oncology, Inc.

Completed

Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants

Healthy Volunteers

United States
Eisai Inc.

Completed

A Study to Evaluate Lemborexant in Milk of Healthy Lactating Women

Healthy Volunteers

United States
Eisai Inc.

Completed

A Study to Assess the Safety and Tolerability of E2730 After Multiple Dose and the Food Effect After Single Dose in Healthy Participants

Healthy Volunteers

United States
Eisai Inc.

Completed

A Study to Assess the Safety and Tolerability of E2511 in Healthy Participants

Healthy Volunteers

United States
Shire

Completed

Effect of Teduglutide on Gastric Emptying in Healthy Subjects

Healthy Volunteers

United States
Genentech, Inc.

Completed

Evaluation of the Relative Bioavailability and Food Effect of GDC-9545 in Healthy Females of Non-Childbearing Potential

Healthy Volunteers

United States
Shanghai Zhimeng Biopharma, Inc.

Completed

A Study of Orally Administered ZM-H1505R to Evaluate Safety, Tolerability and Pharmacokinetics After Single and Multiple Ascending Doses in Healthy Participants

Healthy Volunteers

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Study of Celecoxib Bioavailability in Healthy Subjects

Healthy Volunteers

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Pharmacokinetics Of Celecoxib Test Formulations

Healthy Volunteers

United States
Celgene

Completed

Drug Interaction Study of the Effect on Cyclosporine on Ozanimod and Major Active Metabolites

Healthy Volunteers

United States
Eli Lilly and Company

Completed

A Study of LY2623091 in Healthy Participants

Healthy Volunteers

United States
Amgen

Completed

A Study to Evaluate the Safety, Tolerability Pharmacokinetics, and Pharmacodynamics of a New Spray Dried Dispersion (SDD) Formulation of CC-11050 After Single Dose of CC-11050 and to Evaluate the Pharmacokinetics of CC-11050 Under Fasted and Fed Conditions and After Coadministration With Omeprazole

Healthy Volunteers

United States
Celgene

Completed

Study to Evaluatethe Bioavailability and Food Effect Lenalidomide as an Oral Suspension

Healthy Volunteers

United States
Pfizer

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy Subjects

Healthy Volunteers

United States
Invicro

Completed

Assessment of the Biodistribution and Safety of [18F]MNI-1054

Healthy Volunteers

United States
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

Pediatric Microbiome Study With Children Now Approximately 8-10 Years Old.

Healthy Volunteers

United States
Celgene

Completed

Food Effect and CYP1A2 Induction Study in Healthy Subjects

Healthy Volunteers

United States
Augusta University
American Gastroenterological Association Foundation

Completed

Investigation of Dietary Absorptive Capacity of Fructans in Healthy Subjects - A Dose Response Study

Healthy Volunteers

United States
Washington University School of Medicine

Completed

CYP2B6 Polymorphisms in Ketamine

Healthy Volunteers

United States
Amygdala Neurosciences, Inc.

Completed

A Study to Evaluate the Safety of the Coadministration of ANS-6637 and Ethanol

Healthy Volunteers

United States
Washington University School of Medicine

Completed

LAAM-HAART PET Imaging

Healthy Volunteers

United States
PTC Therapeutics
ICON Development Solutions

Completed

Food Effect and Bioavailability of Deflazacort Formulations in Healthy Volunteers

Healthy Volunteers

United States
Lumos Labs, Inc.

Completed

An Observational Study of Lumosity in Seniors

Healthy Volunteers

United States
AstraZeneca

Completed

To Determine the Relative Bioavailability of Different Formulations of AZD9291 and the Effect of Food.

Healthy Volunteers

United States
Takeda

Completed

Phase 1 TAK-915 Single-Dose Positron Emission Tomography (PET) Occupancy Study

Healthy Volunteers

United States
Pfizer

Completed

Understanding The Effect Of A Strong CYP3A4 Inducer On Glasdegib Pharmacokinetics

Healthy Volunteers

United States
Alkermes, Inc.

Completed

A Study of the Abuse Liability Potential of Samidorphan in Healthy, Non-Dependent, Recreational Opioid Users

Healthy Volunteers

United States
Northern California Institute of Research and Education
U.S. Army Medical Research and Development Command

Completed

Effect of a Hypocretin/Orexin Antagonist on Neurocognitive Performance

Healthy Volunteers

United States
Pfizer

Completed

Study To Determine The Effect Of Food And Strong CYP3A4 Enzyme Inhibitor On PF-04449913 Drug Levels

Healthy Volunteers

United States
AstraZeneca

Completed

A Study to Assess the Bioequivalence of R406 in Healthy Volunteers When Given 100mg and 150 mg of Fostamatinib (Fosta BE)

Healthy Volunteers

United States
AstraZeneca

Completed

A Randomized, Open Label Study to Compare the Current Phase II and Planned Phase III Capsule Formulation of AZD6244 (AZD6244Formula)

Healthy Volunteers

United States
Pfizer

Completed

Study To Investigate The Potential Drug Drug Interaction (DDI) Between PF-00299804 And Paroxetine In Healthy Subjects

Healthy Volunteers

United States
University of California, San Francisco

Completed

Analgesic Tolerance to Repeated Doses of Subcutaneous Morphine

Healthy Volunteers

United States
Pfizer

Terminated

Muscle Malonyl Coa Biomarker Assay Development

Healthy Volunteers

United States
Pfizer

Completed

Drug Interaction Study Between Raltegravir And UK-453,061

Healthy Volunteers

United States
Medical University of South Carolina
GE Healthcare

Completed

The Effect of Contrast Media on Erythrocytes in Healthy Volunteers

Healthy Volunteers

United States
Celgene

Completed

Study to Evaluate Pharmacokinetics of Single Oral Doses of Formulated and Non-Formulated CC-122, and Food Effect Study

Clinical Pharmacology, Healthy Male Volunteer Study

United States
Biogen

Completed

Study to Investigate the Effect of GSK1014802 on Ambulatory Blood Pressure

Healthy Volunteer

United States
Hoffmann-La Roche

Completed

A Study of the Ability of Functional Magnetic Resonance Imaging (fMRI) to Detect and Characterize the Effects of Two Marketed Centrally Active Drugs, Placebo, and RO4917523 in Healthy Volunteers

Healthy Volunteer

United States
Hoffmann-La Roche

Completed

A Study of Three Modified-Release Formulations of RO4917523 in Healthy Volunteers

Healthy Volunteer

United States

3

Subscribe